Side-by-side comparison of AI visibility scores, market position, and capabilities
AI-personalized hair and skincare DTC brand achieved $165M revenue in 2024 with 29% growth; expanded into custom skincare in 2025; manufactures all products in Brooklyn with a West Coast expansion adding production capacity and reducing shipping times.
Prose is a New York-based personalized beauty company founded in 2017 that uses a proprietary algorithm to formulate custom shampoos, conditioners, hair masks, and skincare products based on an individual consumer consultation covering hair type, scalp condition, lifestyle, and environmental factors. The company manufactures all products in small batches in its Brooklyn facility.\n\nProse achieved $165 million in annual revenue in 2024, representing 29% year-over-year growth, making it one of the fastest-scaling DTC beauty brands in the US. In 2025, the company expanded aggressively into custom skincare — applying the same personalization engine to cleansers, serums, and moisturizers — and opened a second customization center on the West Coast to reduce shipping times and scale production capacity.\n\nThe brand released its first national TV advertising campaign in 2025, signaling a move toward broader mainstream awareness beyond its core DTC subscriber base. Prose competes with Function of Beauty in the personalized haircare space but differentiates through in-house manufacturing, dermatologist-reviewed formulas, and a premium pricing tier that skews toward skincare-savvy millennials.
Apple Watch, $18B+ revenue 2024, 22% global smartwatch market share, 34% US wearables market, 100M+ active users, Series 10 (2024): sleep apnea detection, blood oxygen, ECG, fall detection, watchOS 11, fitness tracking leader
Apple Watch was introduced in 2015 as Apple's entry into personal computing worn on the wrist, designed to extend the iPhone experience to the body and provide health and fitness intelligence unavailable from any other consumer device. Apple's mission for the product evolved rapidly from notification delivery to health monitoring, driven by the recognition that continuous, passive measurement of physiological signals could provide clinically meaningful insights at population scale. Its core technology integrates custom Apple silicon, optical heart rate sensors, an electrical heart sensor for ECG, a blood oxygen sensor, and accelerometers within an ultra-compact, water-resistant enclosure running watchOS.\n\nApple Watch Series 10 (2024) introduced sleep apnea detection — a first for any consumer wearable — joining an existing health feature set that includes ECG, irregular heart rhythm notifications, blood oxygen monitoring, crash detection, and fall detection. The Apple Watch platform connects tightly with the Health app and iPhone ecosystem, with third-party app integrations across fitness, medication tracking, mental health, and chronic disease management. Apple Watch serves a broad customer base from fitness-focused consumers to patients with prescribed monitoring needs, supported by FDA clearances on its core health features.\n\nApple Watch generated an estimated $18 billion or more in revenue in 2024, capturing approximately 22% of global smartwatch market share and 34% of the US wearables market, with more than 100 million active users globally. It competes with Samsung Galaxy Watch and Garmin but has no peer in terms of health feature depth, ecosystem integration, and installed base. As regulatory bodies and health systems increasingly recognize wearable-derived data as clinically actionable, Apple Watch's combination of consumer scale and health credibility positions it as the de facto platform for digital health at the consumer level.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.